|
1
|
Han P, Wang X, Liang F, Liu Y, Qiu X, Xu
Y, Chen R, Yu S and Huang X: Osteoradionecrosis of the skull base
in nasopharyngeal carcinoma: Incidence and risk factors. Int J
Radiat Oncol Biol Phys. 102:552–555. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lin K, Qiu F, Chen S, He X, Peng S and
Chen H: Lack of association between the distribution of ABO blood
groups and nasopharyngeal carcinoma in a population of Southern
China. J Cancer Res Ther. 14:785–788. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nakanishi Y, Wakisaka N, Kondo S, Endo K,
Sugimoto H, Hatano M, Ueno T, Ishikawa K and Yoshizaki T:
Progression of understanding for the role of Epstein-Barr virus and
management of nasopharyngeal carcinoma. Cancer Metastasis Rev.
36:435–447. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lin Z, Yang Z, He B, Wang D, Gao X, Tam SY
and Wu VWC: Pattern of radiation-induced thyroid gland changes in
nasopharyngeal carcinoma patients in 48 months after radiotherapy.
PLoS One. 13:e02003102018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hezaveh K, Kloetgen A, Bernhart SH,
Mahapatra KD, Lenze D, Richter J, Haake A, Bergmann AK, Brors B,
Burkhardt B, et al: Alterations of microRNA and microRNA-regulated
messenger RNA expression in germinal center B-cell lymphomas
determined by integrative sequencing analysis. Haematologica.
101:1380–1389. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dallaire A and Simard MJ: The implication
of microRNAs and endo-siRNAs in animal germline and early
development. Dev Biol. 416:18–25. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chai C, Wu H, Wang B, Eisenstat DD and
Leng RP: MicroRNA-498 promotes proliferation and migration by
targeting the tumor suppressor PTEN in breast cancer cells.
Carcinogenesis. 39:1185–1196. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gorbea C, Mosbruger T and Cazalla D: A
viral Sm-class RNA base-pairs with mRNAs and recruits microRNAs to
inhibit apoptosis. Nature. 550:275–279. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen D, Hu S, Wu Z, Liu J and Li S: The
role of MiR-132 in regulating neural stem cell proliferation,
differentiation and neuronal maturation. Cell Physiol Biochem.
47:2319–2330. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang LX, Kang ZP, Yang ZC, Ma RX, Tan Y,
Peng XB, Dai RZ, Li J, Yu Y and Xu M: MicroRNA-135a inhibits
nasopharyngeal carcinoma cell proliferation through targeting
interleukin-17. Cell Physiol Biochem. 46:2232–2238. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bao L, You B, Shi S, Shan Y, Zhang Q, Yue
H, Zhang J, Zhang W, Shi Y, Liu Y, et al: Metastasis-associated
miR-23a from nasopharyngeal carcinoma-derived exosomes mediates
angiogenesis by repressing a novel target gene TSGA10. Oncogene.
37:2873–2889. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jiang N, Jiang X, Chen Z, Song X, Wu L,
Zong D, Song D, Yin L, Wang D, Chen C, et al: MiR-203a-3p
suppresses cell proliferation and metastasis through inhibiting
LASP1 in nasopharyngeal carcinoma. J Exp Clin Cancer Res.
36:1382017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tang T, Huan L, Zhang S, Zhou H, Gu L,
Chen X and Zhang L: MicroRNA-212 functions as a tumor-suppressor in
human non-small cell lung cancer by targeting SOX4. Oncol Rep.
38:2243–2250. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li D, Li Z, Xiong J, Gong B, Zhang G, Cao
C, Jie Z, Liu Y, Cao Y, Yan Y, et al: MicroRNA-212 functions as an
epigenetic-silenced tumor suppressor involving in tumor metastasis
and invasion of gastric cancer through down-regulating PXN
expression. Am J Cancer Res. 5:2980–2997. 2015.PubMed/NCBI
|
|
15
|
Jiang C, Wang H, Zhou L, Jiang T, Xu Y and
Xia L: MicroRNA-212 inhibits the metastasis of nasopharyngeal
carcinoma by targeting SOX4. Oncol Rep. 38:82–88. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ma C, Nong K, Wu B, Dong B, Bai Y, Zhu H,
Wang W, Huang X, Yuan Z and Ai K: miR-212 promotes pancreatic
cancer cell growth and invasion by targeting the hedgehog signaling
pathway receptor patched-1. J Exp Clin Cancer Res. 33:542014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Oliver JR, Kushwah R and Hu J: Multiple
roles of the epithelium-specific ETS transcription factor, ESE-1,
in development and disease. Lab Invest. 92:320–330. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang JL, Chen ZF, Chen HM, Wang MY, Kong
X, Wang YC, Sun TT, Hong J, Zou W, Xu J and Fang JY: Elf3 drives
β-catenin transactivation and associates with poor prognosis in
colorectal cancer. Cell Death Dis. 5:e12632014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zheng L, Xu M, Xu J, Wu K, Fang Q, Liang
Y, Zhou S, Cen D, Ji L, Han W and Cai X: ELF3 promotes
epithelial-mesenchymal transition by protecting ZEB1 from
miR-141-3p-mediated silencing in hepatocellular carcinoma. Cell
Death Dis. 9:3872018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li L and Luo Z: Dysregulated miR-27a-3p
promotes nasopharyngeal carcinoma cell proliferation and migration
by targeting Mapk10. Oncol Rep. 37:2679–2687. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang Y and Xu Z: miR-93 enhances cell
proliferation by directly targeting CDKN1A in nasopharyngeal
carcinoma. Oncol Lett. 15:1723–1727. 2018.PubMed/NCBI
|
|
23
|
Li LN, Xiao T, Yi HM, Zheng Z, Qu JQ,
Huang W, Ye X, Yi H, Lu SS, Li XH and Xiao ZQ: MiR-125b increases
nasopharyngeal carcinoma radioresistance by targeting A20/NF-κB
signaling pathway. Mol Cancer Ther. 16:2094–2106. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cheng JZ, Chen JJ, Wang ZG and Yu D:
MicroRNA-185 inhibits cell proliferation while promoting apoptosis
and autophagy through negative regulation of TGF-β1/mTOR axis and
HOXC6 in nasopharyngeal carcinoma. Cancer Biomark. 23:107–123.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jia P, Wei G, Zhou C, Gao Q, Wu Y, Sun X
and Li X: Upregulation of MiR-212 inhibits migration and
tumorigenicity and inactivates Wnt/β-catenin signaling in human
hepatocellular carcinoma. Technol Cancer Res Treat.
17:15330346187652212018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hu B, Jin X and Wang J: MicroRNA-212
targets mitogen-activated protein kinase 1 to inhibit proliferation
and invasion of prostate cancer cells. Oncol Res. 26:1093–1102.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Song Y, Liu Y and Chen X: MiR-212
attenuates MPP+-induced neuronal damage by targeting
KLF4 in SH-SY5Y cells. Yonsei Med J. 59:416–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu Y, Zhang XL, Li XF, Tang YC and Zhao
X: miR-212-3p reduced proliferation, and promoted apoptosis of
fibroblast-like synoviocytes via down-regulating SOX5 in rheumatoid
arthritis. Eur Rev Med Pharmacol Sci. 22:461–471. 2018.PubMed/NCBI
|
